Leydig cell dysfunction after combination chemotherapy.
D000477:Alkylating Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007985:Leydig Cells / Q000187:drug effects*; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male
D000477:Alkylating Agents